HIGHLIGHTS
- who: Santiago Rodrigues Manica from the CEDOC, Universidade de have published the research work: Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?, in the Journal: (JOURNAL)
- what: The aims of this study were twofold: to compare the efficacy of TNFi as the first-line and second-line therapy and to assess whether the reason for discontinuation of the first TNFi affects the response to the second TNFi in patients with axSpA. For instance, if a patient experienced a severe adverse event by the time of discontinuation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.